CB1 Receptor Activation Provides Neuroprotection in an Animal Model of Glutamate‐Induced Excitotoxicity Through a Reduction of NOX ‐2 Activity and Oxidative Stress
CNS Neuroscience & Therapeutics · 2024
DOI: 10.1111/cns.70099 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2024. Verfasst von Ari Misael Martínez-Torres und 1 weiteren Autor:innen. Beteiligte Einrichtung: División de Neurociencias, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Ciudad de México, Mexico. Hauptthemen laut MEDLINE: Oxidative Stress, NADPH Oxidase 2, Mice, Inbred C57BL, Benzoxazines. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Consejo Nacional de Humanidades, Ciencias y Tecnologías, Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México, Consejo Nacional de Ciencia y Tecnología.
Abstract (Originalsprache)
Background
Excitotoxicity is a process in which NADPH oxidase‐2 (NOX‐2) plays a pivotal role in the generation of reactive oxygen species (ROS). Oxidative stress influences the expression of Aquaporin 4 (AQP4), a water channel implicated in blood–brain barrier (BBB) permeability and edema formation. The endocannabinoid system is widely distributed in the brain, particularly through the cannabinoid receptor type 1 (CB1) and type 2 (CB2), which have been shown to have a neuroprotective function in brain injury. Given the significant involvement of NOX‐2 in ROS production during excitotoxicity, our research aims to assess the participation of NOX‐2 in the neuroprotective effect of the cannabinoid receptor agonist WIN55,212‐2 against glutamate‐induced excitotoxicity damage in the striatum using in vivo model.
Methods
Wild‐type mice (C57BL/6) and NOX‐2 KO (gp91 Cybbtm1Din/J ) were stereotactically injected in the striatum with monosodium glutamate or vehicle. Subsequently, a group of mice was administered an intraperitoneal dose of WIN55,212‐2, AM251, or AM251/WIN55,212‐2 following the intracerebral injection. Motor activity was assessed, and the lesion was examined through histological sections stained with cresyl violet. Additionally, brain water content and Evans blue assay were conducted. The activity of NOX was quantified, and the protein expression of CB1, gp91 phox , AQP4, Iba‐1, TNF‐α, and NF‐κB was analyzed using Western blot. Furthermore, ROS formation was measured through the DHE assay.
Results
The activation of the endocannabinoid receptors demonstrated a neuroprotective response during excitotoxicity, meditated by NOX‐2. The reduction in ROS production led to a decrease in neuroinflammation, and AQP4 expression, resulting in reduced edema formation, and BBB permeability.
Conclusions
During excitotoxic damage, WIN55,212‐2 inhibits NOX‐2‐induced ROS production, reducing brain injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- División de Neurociencias, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Ciudad de México, Mexico.
ORCID-Profile: Julio Morán
Förderung
- Consejo Nacional de Humanidades, Ciencias y Tecnologías
- Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México
- Consejo Nacional de Ciencia y Tecnología
Zitieren
APA
Martínez-Torres, A. M., & Morán, J. (2024). CB1 Receptor Activation Provides Neuroprotection in an Animal Model of Glutamate‐Induced Excitotoxicity Through a Reduction of NOX ‐2 Activity and Oxidative Stress. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.70099
Vancouver
Martínez-Torres AM, Morán J. CB1 Receptor Activation Provides Neuroprotection in an Animal Model of Glutamate‐Induced Excitotoxicity Through a Reduction of NOX ‐2 Activity and Oxidative Stress. CNS Neuroscience & Therapeutics. 2024. doi:10.1111/cns.70099
BibTeX
@article{MartnezTorres2024,
author = {Martínez-Torres, Ari Misael and Morán, Julio},
title = {CB1 Receptor Activation Provides Neuroprotection in an Animal Model of Glutamate‐Induced Excitotoxicity Through a Reduction of NOX ‐2 Activity and Oxidative Stress},
journal = {CNS Neuroscience & Therapeutics},
year = {2024},
doi = {10.1111/cns.70099}
}
EUVIMED